Older women and hormone replacement therapy: Factors influencing late life initiation

Journal of the American Geriatrics Society

Volumn 45, Issue 12, 1997, Pages 1496-1500

  Leveille, Suzanne G ^a   LaCroix, Andrea Z ^b   Newton, Katherine M ^c   Keenan, Nora L ^d,e  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EDUCATION; FEMALE; FRACTURE; HEALTH BEHAVIOR; HEALTH MAINTENANCE ORGANIZATION; HEALTH STATUS; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MARRIAGE; MENOPAUSE; PREVENTIVE MEDICINE; TELEPHONE;

EID: 0030831574     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb03201.x     Document Type: Article

References (28)

1. Lufkin EG, Wahner H\V, O'Fallon \VM et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992;1 17:1-9.
2. Christiansen C, Riis BJ. 17/3-estradiol and continuous norethisterone. A unique treatment for established osteoporosis in elderly women. J Clin EndocrinolMetab 1990;71:836-841.
3. Ott SM. Estrogen therapy for osteoporosis -Even in the elderly (editorial comment). Ann Intern Med 1992;117:85-86.
4. Ettinger B, Grady D. The waning effect of postmenopausal estrogen therapy on osteoporosis. N Engl J Med 1993;329:1192-1193.
5. Grodstcin F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995;38:199-210.
6. Stampfer MJ, Colditz GA, Willett \VC et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten year follow-up from the Nurses' Health Study. N Engl J Med 1991;325:756-762.
7. Wilson PW, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med 1985;313:1038-1043.
8. Stampfer MJ, Colditr GA. Estrogen replacement and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
9. Henderson BE, Paganini-Hill A, Ross RK. Estrogen replacement therapy and protection from acute myocardial infarction. Am J Obstet Gynecol V 1988;159:312-317.
10. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd Ed. New York: Williams and Wilkins, 1995.
11. U.S Congress, Office of Technology Assessment. Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy, Vol. I: CostEffectiveness Analysis (publication no. OTA-BP-H-160).Washington, DC: U.S. Government Printing Office, 1995
12. U.S Congress, Office of Technology Assessment. Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy, Vol. II: Evidence on Benefits, Risks, and Costs (publication no. OTA-BP-H-144). Washington, DC: U.S. Government Printing Office, 1995.
13. Daly E, Roche M, Barlow D et al. HRT: An analysis of benefits, risks, and costs. Br Med Bull 1992;48:368-400.
14. Koster A. Hormone replacement therapy: Use patterns in 51-year-old Danish women. Maturitas 1990;345-356.
15. Roberts PJ. The menopause and hormone replacement therapy: Views of women in general practice receiving hormone replacement therapy. Br J Gen Pract 1991;41:421-424.
16. Mansfield PK, Voda AM. Hormone use among middle-aged women: Results of a three-year study. Menopause. J North Am Menopause Soc 1994;1:99-108.
17. Ferguson KJ, Hoegh C, Johnson S. Estrogen replacement therapy: A survey of women's knowledge and attitudes. Arch Intern Med. 1989;149:133-136.
18. Johannes CB, Crawford SL, Posner JG, McKinlay SM. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 1994;140:439-452.
19. Cauley JA, Cummings SR, Black D et al. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990;163:1438-1444.
20. Handa VL, Landerman R, Hanion JT et al. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE). J Am Geriatr Soc 1996;44:l-6.
21. Salamone LM, Pressman AR, Seeley DG, Cauley JA. Estrogen replacement therapy: A survey of older women's attitudes. Arch Intern Med 1996;156:1293-1297.
22. Groeneveld FPMJ, Bareman FP, Barentsen R et al. Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years. Maturitas 1995;20:81-89.
23. Kritz-Silverstein D, Barret-Connor E, Morion DJ et al. Hysterectomy status and preventive health behaviors in older women. J Women's Health 1993;2:223-229.
24. Barrett-Connor E. Prevalence, initiation, and continuation of hormone replacement therapy. J Women's Health 1995;4:143-148.
25. Nachtigall V. Compliance with hormone therapy. Am J Obstet Gynecol 1987;156:1332-1334.
26. Stumpf PG, Trolice MP. Compliance problems with hormone replacement therapy. Obstet Gynecol Clin North Am 1994;21:219-229.
27. Hunskaar S, Backe B. Attitudes towards and level of information on perimenopausal and postmenopausal hormone replacement therapy among Norwegian women. Maturitas 1992;15:183-194.
28. Hibbard JH, Hampson SE. Enhancing women's partnership with health providers in hormone replacement therapy decision-making: Research and practice directions. J Women Aging 1993;5:17-29.